Novocure (NVCR) Misses Q1 EPS by 9c

Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.42), $0.09 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $23.65 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal